Frequency and Clinical Implications of Discordant Creatine Kinase-MB and Troponin Measurements in Acute Coronary SyndromesL. Kristin Newby, Eric D. Peterson, W. Brian Gibler et al.|Journal of the American College of Cardiology|2006Cited by 75
Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (Results from CRUSADE)Pierluigi Tricoci, Matthew T. Roe, Eric D. Peterson et al.|The American Journal of Cardiology|2007Cited by 22
The impact of emergency department structure and care processes in delivering care for non–ST-segment elevation acute coronary syndromesRajendra H. Mehta, W. Brian Gibler, L. Kristin Newby et al.|American Heart Journal|2006Cited by 19
Heart Failure With Preserved Left Ventricular Systolic Function Among Patients With Non–ST-Segment Elevation Acute Coronary SyndromesKyla M. Bennett, Eric D. Peterson, Adrian F. Hernandez et al.|The American Journal of Cardiology|2007Cited by 16
Relation of Patient Age and Mortality to Reported Contraindications to Early Beta-Blocker Use for Non–ST-Elevation Acute Coronary SyndromeNancy M. Allen LaPointe, Eric D. Peterson, Anita Y. Chen et al.|The American Journal of Cardiology|2009Cited by 9